Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 26;11(1):1625.
doi: 10.4102/ajlm.v11i1.1625. eCollection 2022.

Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso

Affiliations

Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso

Koumpingnin Nebie et al. Afr J Lab Med. .

Abstract

Background: In Burkina Faso, red blood cell (RBC) transfusion remains the crucial anaemia treatment following chronic renal failure (CRF) as erythropoietin and its analogues are unavailable. However, blood group matching beyond the ABO and Rhesus is not common in Burkina Faso. Thus, alloimmunisation is a potential issue for transfused patients.

Objective: Our study aimed to identify anti-erythrocyte antibodies in multi-transfused CRF patients at the Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.

Methods: This cross-sectional study, conducted from October 2018 to November 2019, included CRF patients who had received at least two RBC units. We screened patients for the presence of RBC antibodies using three commercial Cells panels and identified antibody specificities for positive screenings using 11 Cells panels for an indirect antiglobulin test (IAT) in a low ionic strength microcolumn gel-card system.

Results: Two hundred and thirty-five patients (45.1% female; average age: 41.5 years) were included. The median number of blood units received per patient was 10 (interquartile range: 5-20). The overall alloimmunisation rate was 5.9% (14/235). Antibodies identified included: anti-D (1 case), anti-C (1 case), anti-D+C (4 cases), anti-CW (1 case), anti-E (1 case), anti-S (1 case) and anti-Lea (1 case). In four positive patients, the specificity of the antibodies was indeterminate. No risk factors were associated with alloimmunisation.

Conclusion: In Burkina Faso, screening for RBC alloantibodies should be mandated for patients at risk. The high rate of indeterminate antibodies suggests the need to develop a local RBC antibody panel adapted to the local population.

Keywords: Burkina Faso; CRF; RBC antibody; alloimmunisation; blood transfusion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

References

    1. Centre National de Transfusion Sanguine (CNTS) . Annuaire statistiques de la transfusion sanguine 2017. Ouagadougou: CNTS/Ministère de la santé, 2016; p. 128. Report No.: N001.
    1. Institut National de la Statistique et de la Démographie (INSD) . Projections démographiques de 2007 à 2020, par région et province [homepage on the Internet]. Ouagadougou: Institut National de la Statistique et de la Démographie, 2009. [cited 2019 July 23]; p. 69. Available from: http://www.insd.bf/n/contenu/autres_publications/Projections_demographiq...
    1. Barro L, Drew VJ, Poda GG, et al. . Blood transfusion in sub-Saharan Africa: Understanding the missing gap and responding to present and future challenges. Vox Sang. 2018;113(8):726–736. 10.1111/vox.12705 - DOI - PubMed
    1. Yooda AP, Sawadogo S, Soubeiga ST, et al. . Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso. J Blood Med. 2019;10:53–58. 10.2147/JBM.S189079 - DOI - PMC - PubMed
    1. Yooda AP, Soubeiga ST, Nebie KY, et al. . Impact of Multiplex PCR in reducing the risk of residual transfusion-transmitted human immunodeficiency and hepatitis B and C viruses in Burkina Faso. Mediterr J Hematol Infect Dis. 2018;10(1):e2018041. 10.4084/mjhid.2018.041 - DOI - PMC - PubMed

LinkOut - more resources